PIV was found to be superior to traditional inflammation-based markers in discriminating pooc CCC in NSTEMI patients.
No takes yet. Share an insight, caveat, or question.
Toprak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: